MedTrace Logo

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

NCT00768625 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2008-10-08

No results posted yet for this study

Summary

The purpose of this study is:

1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25)
2. To analyze the CPAP treatment over the clinical evolution of OSA patients
3. To determine if OSA is a independent predictor of cardiovascular risk

Conditions

Sponsors & Collaborators

  • Associacao Fundo de Incentivo a Psicofarmcologia

    lead OTHER

Principal Investigators

  • Fatima D Cintra, PhD · Associacao Fundo de Incentivo a Psicofarmcologia

  • Dalva Poyares, PhD · Associacao Fundo de Incentivo a Psicofarmcologia

  • Sergio Tufik, PhD · Associacao Fundo de Incentivo a Psicofarmcologia

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2011-03-31
Completion
2012-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768625 on ClinicalTrials.gov